MEI Pharma (MEIP) Insider Trading & Ownership

$3.05

+0.02 (+0.66%)

(As of 09/16/2024 ET)

Current Insider Ownership Percentage: 3.90%
Number Of Insiders Buying (Last 12 Months): 1
Amount Of Insider Buying (Last 12 Months): $1.05 M
Number Of Insiders Selling (Last 12 Months): 0

Get MEIP Insider Trade Alerts

Want to know when executives and insiders are buying or selling MEI Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MEIP Insider Buying and Selling by Quarter

Ad Brownstone Research

Bill Gates’ Next Big Thing: “Exegesis AI”

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate

MEI Pharma Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
9/22/2023	Anson Funds Management Lp	Major Shareholder	Buy	48,060	$6.85	$329,211.00
9/20/2023	Anson Funds Management Lp	Major Shareholder	Buy	120,000	$6.01	$721,200.00

(Data available from 1/1/2013 forward)

MEIP Insider Trading Activity - Frequently Asked Questions

: The list of insiders at MEI Pharma includes Anson Funds Management Lp, and Charles V Baltic III. Learn more on insiders at MEIP.
: 3.90% of MEI Pharma stock is owned by insiders. Learn more on MEIP's insider holdings.
: The following insiders have purchased MEIP shares in the last 24 months: Anson Funds Management Lp ($1,050,411.00), and Charles V Baltic III ($18,745.00).
: Insiders have purchased a total of 172,135 MEIP shares in the last 24 months for a total of $1,069,156.00 bought.